Title of article
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy
Author/Authors
Ghaffari، نويسنده , , Sasan and Kereiakes، نويسنده , , Dean J. and Lincoff، نويسنده , , A.Michael and Kelly، نويسنده , , Thomas A. and Timmis، نويسنده , , Gerald C. and Kleiman، نويسنده , , Neal S. and Ferguson، نويسنده , , James J. and Miller، نويسنده , , David P. and Califf، نويسنده , , Robert A. and Topol، نويسنده , , Eric J.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1998
Pages
6
From page
7
To page
12
Abstract
We determined the efficacy of abciximab, a platelet glycoprotein IIb/IIIa receptor antagonist, combined with low-dose weight-adjusted heparin in reducing ischemic complications in patients undergoing directional coronary atherectomy (DCA). The Evaluation
Journal title
American Journal of Cardiology
Serial Year
1998
Journal title
American Journal of Cardiology
Record number
1887565
Link To Document